Brief: Xpro1595 Improves Outcomes In A Mouse Model Of Tbi-Induced Alzheimer’S Disease
19/04/2023 13:33
April 19 (Reuters) - INmune Bio Inc INMB.O :
* XPRO1595 IMPROVES OUTCOMES IN A MOUSE MODEL OF TBI-INDUCED
ALZHEIMER’S DISEASE
Source text for Eikon: ID:nGNXc9m4n6
Further company coverage: INMB.O
Recent news on Inmune Bio
See all newsBrief: Inmune Bio - Enters Master Services Agreement With Uniphar For Ebstrocel International Commercialization
Brief: Inmune Bio Targets UK Maa In Q4 2026, EU Maa And US BLA In Q1 2027
INmune Bio Inc reports results for the quarter ended June 30 - Earnings Summary
INmune Bio Q2 net loss narrows on lower impairment charges
INmune Bio Inc expected to post a loss of 21 cents a share - Earnings Preview